Pegasus Hava Tasimaciligi Anonim Sirketi
BIST:PGSUS.IS
240.1 (TRY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TRY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 70,531.532 | 42,732.214 | 10,664.407 | 4,803.56 | 11,025.225 | 8,296.736 | 5,348.573 | 3,707.471 | 3,488.271 | 3,081.728 | 2,404.06 | 1,919.446 |
| Cost of Revenue
| 54,010.796 | 31,155.508 | 10,546.869 | 6,133.761 | 8,471.382 | 7,104.097 | 4,636.256 | 3,564.919 | 3,098.127 | 2,653.041 | 1,981.995 | 1,621.984 |
| Gross Profit
| 16,520.735 | 11,576.706 | 117.538 | -1,330.201 | 2,553.843 | 1,192.639 | 712.318 | 142.552 | 390.144 | 428.686 | 422.065 | 297.462 |
| Gross Profit Ratio
| 0.234 | 0.271 | 0.011 | -0.277 | 0.232 | 0.144 | 0.133 | 0.038 | 0.112 | 0.139 | 0.176 | 0.155 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 855.738 | 404.85 | 179.21 | 135.284 | 107.84 | 90.14 | 73.017 | 60.777 | 38.125 | 28.108 | 26.844 | 20.437 |
| Selling & Marketing Expenses
| 1,058.06 | 757.552 | 229.671 | 130.018 | 253.431 | 192.554 | 160.517 | 160.869 | 135.126 | 118.751 | 93.265 | 71.738 |
| SG&A
| 2,680.082 | 1,162.403 | 408.881 | 265.302 | 361.271 | 282.694 | 233.534 | 221.646 | 173.251 | 146.859 | 120.109 | 92.175 |
| Other Expenses
| -4.742 | 913.731 | 265.855 | 41.694 | 125.317 | 99.524 | 69.656 | 66.569 | 39.709 | 0.21 | 0.178 | 12.345 |
| Operating Expenses
| 2,684.824 | 2,076.134 | 674.736 | 306.996 | 486.588 | 382.218 | 303.19 | 288.215 | 212.961 | 182.629 | 151.49 | 104.521 |
| Operating Income
| 13,835.911 | 9,675.474 | -1,013.193 | -1,033.533 | 2,061.983 | 791.722 | 461.742 | -105.955 | 243.535 | 324.702 | 258.091 | 201.801 |
| Operating Income Ratio
| 0.196 | 0.226 | -0.095 | -0.215 | 0.187 | 0.095 | 0.086 | -0.029 | 0.07 | 0.105 | 0.107 | 0.105 |
| Total Other Income Expenses Net
| -3,741.073 | -3,056.525 | -1,043.592 | -991.311 | -667.718 | -249.456 | 141.526 | -37.715 | -61.156 | -189.028 | -103.418 | -46.481 |
| Income Before Tax
| 10,094.838 | 6,618.948 | -2,056.786 | -2,024.845 | 1,394.265 | 542.266 | 603.268 | -143.67 | 182.379 | 135.674 | 154.673 | 155.32 |
| Income Before Tax Ratio
| 0.143 | 0.155 | -0.193 | -0.422 | 0.126 | 0.065 | 0.113 | -0.039 | 0.052 | 0.044 | 0.064 | 0.081 |
| Income Tax Expense
| -10,792.818 | -481.197 | -84.307 | -59.748 | 59.697 | 40.149 | 102.205 | -7.487 | 70.515 | -7.633 | 66.361 | 29.016 |
| Net Income
| 20,907.502 | 7,100.145 | -1,972.478 | -1,965.097 | 1,333.369 | 507.379 | 502.248 | -133.731 | 113.126 | 143.342 | 91.684 | 126.304 |
| Net Income Ratio
| 0.296 | 0.166 | -0.185 | -0.409 | 0.121 | 0.061 | 0.094 | -0.036 | 0.032 | 0.047 | 0.038 | 0.066 |
| EPS
| 41.82 | 14.2 | -3.94 | -3.93 | 2.67 | 1.01 | 1 | -0.27 | 0.23 | 0.29 | 0.2 | 1.68 |
| EPS Diluted
| 41.82 | 14.2 | -3.94 | -3.93 | 2.67 | 1.01 | 1 | -0.27 | 0.23 | 0.29 | 0.2 | 1.68 |
| EBITDA
| 21,639.089 | 13,195.982 | 1,803.108 | 1,149.87 | 3,385.78 | 1,267.039 | 760.234 | 106.263 | 496.263 | 456.824 | 314.958 | 266.012 |
| EBITDA Ratio
| 0.307 | 0.309 | 0.169 | 0.239 | 0.307 | 0.153 | 0.142 | 0.029 | 0.142 | 0.148 | 0.131 | 0.139 |